Table 3.
ETI (n = 21) | Control (n = 21) | p-value | |
---|---|---|---|
Postoperative complications | |||
Pulmonarya | 17(81.0%) | 4(19.0%) | 0.000 |
Cardiaca | 12(57.1%) | 8(38.1%) | 0.217 |
Anastomotic leaka | 9(42.9%) | 2(9.5%) | 0.014 |
Hepatica | 9(42.9%) | 6(28.6%) | 0.334 |
Renala | 1(4.8%) | 0(0%) | |
Thromboembolica | 7(33.3%) | 2(9.5%) | 0.133 |
Electrolyte disordera | 17(81.0%) | 7(33.3%) | 0.002 |
Postoperative bleedinga | 2(9.5%) | 0(0%) | 0.469 |
Sepsisa | 3(14.3%) | 0(0%) | 0.231 |
Shocka | 5(23.8%) | 0(0%) | 0.057 |
Clinical outcomes | |||
Reoperationsa | 12(57.1%) | 1(4.8%) | 0.000 |
PLOS (days) b | 38.17 ± 21.41 | 17.67 ± 9.41 | 0.000 |
Charge (*103 RMB) b | 198.55 ± 15.94 | 88.75 ± 11.85 | 0.000 |
In-hospital Mortalitya | 4(19.0%) | 0(0%) | |
3-year OSa | 10(47.6%) | 18(85.7%) | 0.018 |
Data are presented as number (percentage), or ratio or mean ± standard deviation
ETI Emergent endotracheal intubation, PLOS Post-operative length of stay, OS Overall survival
aChi-square
bTwo-tailed Student’s t test